Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by gojotv!on Apr 27, 2021 12:40pm
138 Views
Post# 33074877

SIX patients cancer free!

SIX patients cancer free!Several others in varying stages of response or as yet undetermined... That makes Theralase the undisputed best treatment modality for difficult bladder cancers.
Everyone who has bladder cancer will want this treatment FIRST, because of its non-toxicity, its ease, and the ability to go home immdiately, with no hospital stay.
This is fantastic news for shareholders!
TLT is headed for the #1 spot in cancer treatment protocols.
And remember, the company gets paid for the treatment, regardless of the response.
Six cured and several improved patients is an excellent preliminary result.
It's enough to launch this modality, and can only get better as treatment optimizes!
Go, TLT, go!


<< Previous
Bullboard Posts
Next >>